Back to Menu
1. Clinical assessment
Evaluate lesion morphology and warning signs, combined with history and rate of change, to form an initial differential diagnosis.
2. Dermoscopy
A noninvasive technique to visualize subsurface patterns and structures, improving diagnostic accuracy and helping reduce unnecessary biopsies.
3. Pathologic biopsy
The diagnostic gold standard. Excisional or punch/incisional biopsy provides definitive tumor type and invasion depth (e.g., Breslow thickness for melanoma).
4. Reflectance confocal microscopy (RCM)
Real-time, noninvasive “optical biopsy” that supports diagnosis and helps define lesion margins, particularly for selected equivocal lesions.
5. Imaging studies
Ultrasound can assess thickness and regional lymph nodes; CT/MRI evaluate deep invasion and metastasis when clinically indicated.
6. Fluorescence-based skin diagnostics
Fluorescence under specific wavelengths may aid detection of some early lesions, but it is adjunctive and does not replace pathology.
7. Molecular testing
Detection of actionable alterations (e.g., BRAF, KIT, NRAS in melanoma) supports prognostic stratification and selection of targeted therapy when applicable.
8. Immunohistochemistry
Markers (e.g., SOX10, S100, Melan-A for melanocytic lesions; p40/p63 for squamous differentiation) assist in difficult or ambiguous cases.
9. Self-examination
Monthly full-skin checks using the ABCDE rule and attention to “ugly duckling” lesions; seek medical evaluation for any suspicious change.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that delayed diagnosis and treatment of skin cancer can lead to extensive local destruction and distant metastasis, posing a serious threat to life. Prognosis varies markedly by subtype; early detection is pivotal. Improving public awareness, performing regular self-examinations, and obtaining timely professional assessment — with precise diagnosis guiding individualized management — are essential to improving treatment outcomes.
1. Clinical assessment
Evaluate lesion morphology and warning signs, combined with history and rate of change, to form an initial differential diagnosis.
2. Dermoscopy
A noninvasive technique to visualize subsurface patterns and structures, improving diagnostic accuracy and helping reduce unnecessary biopsies.
3. Pathologic biopsy
The diagnostic gold standard. Excisional or punch/incisional biopsy provides definitive tumor type and invasion depth (e.g., Breslow thickness for melanoma).
4. Reflectance confocal microscopy (RCM)
Real-time, noninvasive “optical biopsy” that supports diagnosis and helps define lesion margins, particularly for selected equivocal lesions.
5. Imaging studies
Ultrasound can assess thickness and regional lymph nodes; CT/MRI evaluate deep invasion and metastasis when clinically indicated.
6. Fluorescence-based skin diagnostics
Fluorescence under specific wavelengths may aid detection of some early lesions, but it is adjunctive and does not replace pathology.
7. Molecular testing
Detection of actionable alterations (e.g., BRAF, KIT, NRAS in melanoma) supports prognostic stratification and selection of targeted therapy when applicable.
8. Immunohistochemistry
Markers (e.g., SOX10, S100, Melan-A for melanocytic lesions; p40/p63 for squamous differentiation) assist in difficult or ambiguous cases.
9. Self-examination
Monthly full-skin checks using the ABCDE rule and attention to “ugly duckling” lesions; seek medical evaluation for any suspicious change.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that delayed diagnosis and treatment of skin cancer can lead to extensive local destruction and distant metastasis, posing a serious threat to life. Prognosis varies markedly by subtype; early detection is pivotal. Improving public awareness, performing regular self-examinations, and obtaining timely professional assessment — with precise diagnosis guiding individualized management — are essential to improving treatment outcomes.